Although published survival predictions derived from time-fixed covariates vary significantly between stage I, II, and III cancers and between ER/PR+ and ER/PR− cancers, all four of the predictive models demonstrated the same narrow range of inaccuracy when trained on time-fixed covariates and all improved relatively equally to highly accurate estimates when we incorporated time-varying covariates into the modeling. Here, ESR1 is linked to cancer.